Vanguard Group’s Athira Pharma ATHA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $464K | Hold |
1,537,914
| – | – | ﹤0.01% | 3936 |
|
|
2025
Q1 | $438K | Sell |
1,537,914
-18,737
| -1% | -$5.34K | ﹤0.01% | 3917 |
|
|
2024
Q4 | $914K | Sell |
1,556,651
-56,412
| -3% | -$33.1K | ﹤0.01% | 3791 |
|
|
2024
Q3 | $719K | Sell |
1,613,063
-21,370
| -1% | -$9.53K | ﹤0.01% | 3868 |
|
|
2024
Q2 | $4.33M | Hold |
1,634,433
| – | – | ﹤0.01% | 3315 |
|
|
2024
Q1 | $4.48M | Sell |
1,634,433
-64,020
| -4% | -$175K | ﹤0.01% | 3342 |
|
|
2023
Q4 | $4.13M | Hold |
1,698,453
| – | – | ﹤0.01% | 3356 |
|
|
2023
Q3 | $3.43M | Hold |
1,698,453
| – | – | ﹤0.01% | 3406 |
|
|
2023
Q2 | $5.01M | Sell |
1,698,453
-144,192
| -8% | -$425K | ﹤0.01% | 3299 |
|
|
2023
Q1 | $4.61M | Buy |
1,842,645
+4,712
| +0.3% | +$11.8K | ﹤0.01% | 3345 |
|
|
2022
Q4 | $5.83M | Buy |
1,837,933
+5,903
| +0.3% | +$18.7K | ﹤0.01% | 3233 |
|
|
2022
Q3 | $5.44M | Buy |
1,832,030
+221,450
| +14% | +$658K | ﹤0.01% | 3280 |
|
|
2022
Q2 | $4.91M | Buy |
1,610,580
+99,502
| +7% | +$303K | ﹤0.01% | 3382 |
|
|
2022
Q1 | $20.4M | Sell |
1,511,078
-24,163
| -2% | -$326K | ﹤0.01% | 2763 |
|
|
2021
Q4 | $20M | Sell |
1,535,241
-106,242
| -6% | -$1.38M | ﹤0.01% | 2839 |
|
|
2021
Q3 | $15.4M | Buy |
1,641,483
+273,884
| +20% | +$2.57M | ﹤0.01% | 2997 |
|
|
2021
Q2 | $14M | Buy |
1,367,599
+588,131
| +75% | +$6.02M | ﹤0.01% | 3036 |
|
|
2021
Q1 | $14.3M | Buy |
779,468
+133,303
| +21% | +$2.45M | ﹤0.01% | 2960 |
|
|
2020
Q4 | $22.1M | Buy |
646,165
+546,165
| +546% | +$18.7M | ﹤0.01% | 2590 |
|
|
2020
Q3 | $1.85M | Buy |
+100,000
| New | +$1.85M | ﹤0.01% | 3506 |
|